40780_2019_133_MOESM3_ESM.pdf (78.64 kB)
Additional file 3: of Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study
journal contribution
posted on 2019-02-13, 05:00 authored by Eri Wakai, Kenji Ikemura, Hiroko Sugimoto, Takuya Iwamoto, Masahiro OkudaFigure S2: Distribution of patients classified by the number of suggested risk factors for hypermagnesemia in patients without serum Mg monitoring (nâ=â2542). Values are presented as number (%). (PDF 78 kb)